Most published systematic reviews of remdesivir for COVID-19 were redundant and lacked currency.

McDonald, Steve; Turner, Simon; Page, Matthew J; Turner, Tari

McDonald, Steve; Turner, Simon; Page, Matthew J; Turner, Tari.

Afiliación

McDonald S; Cochrane Australia, School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC Australia. Electronic address: steve.mcdonald@monash.edu.
Turner S; Methods in Evidence Synthesis Unit, School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC Australia.
Page MJ; Methods in Evidence Synthesis Unit, School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC Australia.
Turner T; Cochrane Australia, School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC Australia.

J Clin Epidemiol ; 146: 22-31, 2022 06.

Article en En | MEDLINE | ID: mdl-35192923

Asunto(s)

Tratamiento Farmacológico de COVID-19; Adenosina Monofosfato/análogos & derivados; Alanina/análogos & derivados; Australia; Estudios Transversales; Humanos; Revisiones Sistemáticas como Asunto

Palabras clave

COVID-19; Living evidence; PROSPERO; Remdesivir; Systematic reviews

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Tratamiento Farmacológico de COVID-19 Tipo de estudio: Clinical_trials / Guideline / Observational_studies / Prevalence_studies / Risk_factors_studies / Systematic_reviews Límite: Humans País/Región como asunto: Oceania Idioma: En Revista: J Clin Epidemiol Asunto de la revista: EPIDEMIOLOGIA Año: 2022 Tipo del documento: Article

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google